1. Home
  2. SBFM vs CYN Comparison

SBFM vs CYN Comparison

Compare SBFM & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • CYN
  • Stock Information
  • Founded
  • SBFM 2006
  • CYN 2013
  • Country
  • SBFM United States
  • CYN United States
  • Employees
  • SBFM N/A
  • CYN N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • CYN EDP Services
  • Sector
  • SBFM Health Care
  • CYN Technology
  • Exchange
  • SBFM Nasdaq
  • CYN Nasdaq
  • Market Cap
  • SBFM 7.7M
  • CYN 7.5M
  • IPO Year
  • SBFM N/A
  • CYN 2021
  • Fundamental
  • Price
  • SBFM $1.43
  • CYN $13.60
  • Analyst Decision
  • SBFM Strong Buy
  • CYN
  • Analyst Count
  • SBFM 1
  • CYN 0
  • Target Price
  • SBFM $15.00
  • CYN N/A
  • AVG Volume (30 Days)
  • SBFM 85.2K
  • CYN 10.2M
  • Earning Date
  • SBFM 08-15-2025
  • CYN 08-06-2025
  • Dividend Yield
  • SBFM N/A
  • CYN N/A
  • EPS Growth
  • SBFM N/A
  • CYN N/A
  • EPS
  • SBFM N/A
  • CYN N/A
  • Revenue
  • SBFM $36,234,578.00
  • CYN $409,777.00
  • Revenue This Year
  • SBFM $192.48
  • CYN $1,162.03
  • Revenue Next Year
  • SBFM N/A
  • CYN $427.83
  • P/E Ratio
  • SBFM N/A
  • CYN N/A
  • Revenue Growth
  • SBFM 35.51
  • CYN N/A
  • 52 Week Low
  • SBFM $1.17
  • CYN $3.62
  • 52 Week High
  • SBFM $9.30
  • CYN $1,600.50
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 48.48
  • CYN 91.45
  • Support Level
  • SBFM $1.41
  • CYN $3.94
  • Resistance Level
  • SBFM $1.58
  • CYN $4.83
  • Average True Range (ATR)
  • SBFM 0.12
  • CYN 2.40
  • MACD
  • SBFM -0.01
  • CYN 0.61
  • Stochastic Oscillator
  • SBFM 18.91
  • CYN 25.70

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: